Download PDF
Semin intervent Radiol 2003; 20(4): 275-278
DOI: 10.1055/s-2004-828938
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Radiofrequency Ablation: A Medical Oncology Perspective

George Zahrah, Howard Safran
  • The Brown University Oncology Group, The Rhode Island and Miriam Hospitals, Providence, Rhode Island; Associate Professor of Medicine
Further Information

Publication History

Publication Date:
20 July 2004 (online)

Also available at
    Permissions and Reprints

ABSTRACT

This article outlines the medical oncologist's perspective of the value of radiofrequency ablation, and the treatment of various tumors. A number of studies are described that have been published on the treatment of hepatic, renal, and lung tumors. The authors provide their opinion on the value of radiofrequency ablation to treat such tumors.

KEYWORDS

Oncology - hepatic tumors - renal tumors

REFERENCES

  • 1 Di Bisceglie M A, Rustgi V K, Hoofnagle J H. et al . NIH conference-Hepatocellular carcinoma.  Ann Intern Med . 1988;  108 390-401
    PubMedGoogle Scholar
  • 2 Barnett Jr C C, Curley S A. Ablative techniques for hepatocellular carcinoma.  Semin Oncol . 2001;  28 487-496
    CrossrefPubMedGoogle Scholar
  • 3 Curley S A, Izzo F, Ellis L M. et al . Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.  Ann Surg . 2000;  232 381-391
    CrossrefPubMedGoogle Scholar
  • 4 Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma.  Eur J Ultrasound . 2001;  13(2) 159-166
    CrossrefPubMedGoogle Scholar
  • 5 Livraghi T, Goldberg S N, Lazzaroni S. et al . Small hepatoceullar carcinoma: Treatment with radio-frequency ablation versus ethanol injection.  Radiology . 1999;  210 655-661
    CrossrefPubMedGoogle Scholar
  • 6 Olschewski M, Lencioni R, Allgaier H. et al . A randomized comparison of radiofrequency thermal ablation and percutaneous ethanol ablation for the treatment of small hepatocellular carcinoma.  Proc Am Soc Clin Oncol . 2001;  20 126A
    PubMedGoogle Scholar
  • 7 Geoghegan J G, Scheele J. Treatment of colorectal liver metastases.  Br J Surg . 1999;  86(2) 158-169
    CrossrefPubMedGoogle Scholar
  • 8 Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases.  Eur J Ultrasound . 2001;  13 149-158
    CrossrefPubMedGoogle Scholar
  • 9 de Baere T, Elias D, Dromain C. et al . Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.  AJR Am J Roentgenol . 2000;  175 1619-1625
    PubMedGoogle Scholar
  • 10 Curley S A, Izzo F, Delrio P. et al . Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.  Ann Surg . 1999;  230 1-8
    CrossrefPubMedGoogle Scholar
  • 11 Solbiati L, Livraghi T, Goldberg S N. et al . Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.  Radiology . 2001;  221 159-166
    CrossrefPubMedGoogle Scholar
  • 12 Jain S K, Dupuy D E, Cardarelli G A, Zheng Z, DiPetrillo T A. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy.  AJR Am J Roentgenol . 2003;  181 711-715
    CrossrefPubMedGoogle Scholar
  • 13 Mayo-Smith W W, Dupuy D E, Parikh P M, Pezzullo J A, Cronan J J. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.  AJR Am J Roentgenol . 2003;  180 1503-1508
    CrossrefPubMedGoogle Scholar
      >